All lobbying filings

INDIVIOR INC

Lobbying for INDIVIOR INC

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate · $250,000.00 expenses · posted Oct 20, 2025

Official filing document

Bills named in this filing 5

HR 2483
SUPPORT for Patients and Communities Reauthorization Act of 2025
HR 27
HALT Fentanyl Act
HR 2586
Reentry Act of 2025
HR 1510
Due Process Continuity of Care Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 1

Health Issues

SUPPORT for Patients and Communities Reauthorization Act (HR 2483); HALT Fentanyl Act (HR 27 / S 331); Reentry Act (HR 2586); Due Process Continuity of Care Act (HR 1510); One Big Beautiful Bill Act (HR 1); FY26 appropriations for Labor-HHS-Education, Military Construction and Veterans Affairs, and Commerce-Justice-Science; DEA rulemaking on telemedicine prescribing of controlled substances (RIN #1117-AB40).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.